Histological evaluation of rat mammary tumours after treatment with retinoic acid analogues - phytol, TTNPB and vitamin D3 analogue seocalcitol

Biologia

Volumn 66, Issue 2, 2011, Pages 365-369

  Líška, Ján ^a,b   Ondková, Slavomíra ^b   Macejová, Dana ^b   Brtko, Július ^b  

^a Bratislava   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

1 methyl 1 nitrosourea; mammary tumours; phytol; rats; seocalcitol; TTNPB

Indexed keywords

RATTUS;

EID: 79951776787     PISSN: 00063088     EISSN: 13369563     Source Type: Journal    
DOI: 10.2478/s11756-011-0024-3     Document Type: Article

References (28)

1. Brtko J. 2007. Retinoids, rexinoids and their cognate nuclear receptors: character and their role in chemoprevention of selected malignant diseases. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 151: 187-194.
2. Colston K. W., Pirianov G., Bramm E., Hamberg K. J. & Binderup L. 2003. Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors. Breast Cancer Res. Treat. 80: 303-311.
3. Jiménez-Lara A. M., Aranda A. & Gronemeyer H. 2010. Retinoic acid protects human breast cancer cells against etoposideinduced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms. Mol. Cancer 9: 15.
4. Kitareevan S., Burka L. T., Tomer K. B., Parker C. E., Deterding L. J., Stevens R. D., Forman B. M., Mais D. E., Heyman R. A., McMorris T. & Weinberger C. 1996. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol. Biol. Cell 7: 1153-1166.
5. Koay D. C., Zerillo C., Narayan M., Harris L. N. & DiGiovanna M. P. 2010. Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations. Breast Cancer Res. 12: R62.
6. Koshizuka K., Kubota T., Said J., Koike M., Binderup L., Uskokovic M. & Koeffler H. P. 1999. Combination therapy of a vitamin D3 analog and all-trans-retinoic acid: effect on human breast cancer in nude mice. Anticancer Res. 19: 519-524.
7. Lemotte P. K., Keidel S. & Apfel C. M. 1996. Phytanic acid is a retinoid X receptor ligand. Eur. J. Biochem. 236: 328-333.
8. Lšíka J., Galbavy Š., Zlatoš J., Macejová D., Mičincová M. & Brtko, J. 2000. Mammary tumours in female rats developed after 1-methyl-1-nitrosourea treatment. Biologia 55(Suppl. 8): 63-67.
9. Lšíka J., Macejová D., Galbavy Š., Baranová M., Zlatoš J., Štvrtina S. Mostböck S., Weiss R., Scheiblhofer S., Thalhamer J. & Brtko J. 2003. Treatment of 1-methyl-1-nitrosoureainduced mammary tumours with immunostimulatory CpG motifs and in female rats: histopathological study. Exp. Toxicol. Pathol. 55: 173-179.
10. Loeliger P., Bollag W. & Mayer H. 1980. Arotinoids, a new class of highly active retinoids. Eur. J. Med. Chem. 1: 9-15.
11. Macejová D., Dvorčáková M., Weiss R., Scheiblhofer S., Mostböck S., Lšíka J., Szabová E., Zórad Š., Thalhamer J. & Brtko J. 2001. Reduction of 1-methyl-1-nitrosourea-induced mammary gland carcinoma by in vivo application of immunostimulatory CpG motifs in Sprague-Dawley rats. Gen. Physiol. Biophys. 20: 445-448.
12. Macejová D., Ondková S. & Brtko J. 2009. Vitamin D3 affects expression of thyroid hormone receptor alpha and deiodinase activity in liver of MNU-treated Sprague-Dawley rats. Gen. Physiol. Biophys. 28: 425-427.
13. McCormick D. L., Adamowski C. B., Fiks A. & Moon R. C. 1981. Lifetime dose response relationships for mammmary tumor induction by a single administration of N-methyl-Nnitrosourea. Cancer Res. 41: 1690-1694.
14. Montesano R & Soulié P. 2002. Retinoids induce lumen morphogenesis in mammary epithelial cells. J. Cell Sci. 115: 4419-4431.
15. Moon R. C. 1989. Comparative aspects of carotenoids and retinoids as chemopreventive agents for cancer. J. Nutr. 119: 127-134.
16. Ondková S, Macejová D. & Brtko J. 2006. Role of dihydroxyvitamin D(3) and its nuclear receptor in novel directed therapies for cancer. Gen. Physiol. Biophys. 25: 339-353.
17. Pignatello M. A., Kauffman F. C. & Levin A. A. 1999. Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): interactions with the retinoic acid receptors. Toxicol. Appl. Pharmacol. 159: 109-116.
18. Rose D. P., Pruitt B., Stauber P., Erturk E. & Bryan G. T. 1980. Influence of dosage schedule on the biological characteristics of N-nitrosomethylurea-induced rat mammary tumors. Cancer Res. 40: 235-239.
19. Russo J., Russo I. H., Rogers A. E., van Zwieten M. J. & Gusterson B. 1990. Tumours of mammary gland, pp. 47-48. In: Turusov V. & Mohr U. (eds). Pathology of Tumours in Laboratory Animals. Vol. 1, Tumours of the Rat. IARC Scientific Publications, Lyon.
20. Russo J., Wilgus G. & Russo I. H. 1979. Susceptibility of the mammary gland to carcinogenesis. Diferentiation of the mammary gland as determinant of tumor incidence and the type of lesion. Am. J. Pathol. 96: 721-734.
21. Strickland S., Breitman T. R., Frickel F., Nürrenbach A., Hädicke E. & Sporn M. B. 1983. Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. Cancer Res. 43: 5268-5272.
22. Takahashi H., Uemura Y., Nakao I. & Tsubura A. 1995. Induction of mammary carcinomas by the direct application of crystalline N-methyl-N-nitrosourea onto rat mammary gland. Cancer Lett. 92: 105-111.
23. Thompson H. J. & Adlakha H. 1991: Dose-responsive induction of mammary gland carcinomas by the intraperitoneal injection of 1-methyl-1-nitrosourea. Cancer Res. 51: 3411-3415.
24. Thompson H. J., Mcginley J. N., Rothhammer K. & Singh M. 1995. Rapid induction of mammary intraductal proliferation, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis 16: 2407-2411.
25. Welsch C. W. 1985. Host factors affecting the growth of carcinogeninduced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res. 45: 3415-3443.
26. Wu K., DuPre E., Kim H. T. Tin U. C. K. Bissonnette R. P., Lamph W. W. & Brown P. H. 2006. Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade. Breast Cancer Res. Treat. 96: 147-157.
27. Wu K., Kim H. T., Rodriquez J. L., Hilsenbeck S. G., Mohsin S. K., Xu X. C., Lamph W. W., Kuhn J. G., Green J. E. & Brown P. H. 2002. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069. Cancer Epidemiol. Biomarkers Prev. 11: 467-474.
28. Yanase T., Mu Y. M., Nishi Y., Goto K., Nomura M., Okabe T., Takayanagi R. & Nawata H. 2001. Regulation of aromatase by nuclear receptors. J. Steroid Biochem. Mol. Biol. 79: 187-192.